These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33099695)

  • 1. Statistical Considerations in Assessing In Vivo Adhesion with Transdermal and Topical Delivery Systems for New Drug Applications.
    Wang C; Strasinger C; Shen M; Tsong Y
    AAPS J; 2020 Oct; 22(6):137. PubMed ID: 33099695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical considerations and impact of the FDA draft guidance for assessing adhesion with transdermal delivery systems and topical patches for ANDAs.
    Sun W; Grosser S; Kim C; Raney SG
    J Biopharm Stat; 2019; 29(5):952-970. PubMed ID: 31495266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical attributes of transdermal drug delivery system (TDDS)--a generic product development review.
    Ruby PK; Pathak SM; Aggarwal D
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1421-8. PubMed ID: 24467407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Artificial Intelligence to Improve the Calculation of Percent Adhesion for Transdermal and Topical Delivery Systems.
    Wang C; Strasinger C; Weng YT; Zhao X
    J Med Syst; 2023 Dec; 48(1):4. PubMed ID: 38105364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies.
    Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P
    Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis.
    La Count TD; Zhang Q; Murawsky M; Hao J; Ghosh P; Dave K; Raney SG; Talattof A; Kasting GB; Li SK
    AAPS J; 2020 Jun; 22(4):82. PubMed ID: 32488395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic patches containing fentanyl: In vitro equivalence and abuse deterrent evaluation according to EMA and FDA guidelines.
    Padula C; Pescina S; Nicoli S; Santi P
    Int J Pharm; 2018 Feb; 537(1-2):57-63. PubMed ID: 29253583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic drug device combination products: Regulatory and scientific considerations.
    Choi SH; Wang Y; Conti DS; Raney SG; Delvadia R; Leboeuf AA; Witzmann K
    Int J Pharm; 2018 Jun; 544(2):443-454. PubMed ID: 29170118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesive properties: a critical issue in transdermal patch development.
    Cilurzo F; Gennari CG; Minghetti P
    Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of residual solvents on the physical properties of transdermal drug delivery systems.
    Mazumder S; Shakleya D; Mattson S; Ashraf M; Faustino P; Pavurala N
    Int J Pharm; 2020 Oct; 588():119713. PubMed ID: 32755689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.
    Basak AK; Raw AS; Al Hakim AH; Furness S; Samaan NI; Gill DS; Patel HB; Powers RF; Yu L
    Adv Drug Deliv Rev; 2007 Jan; 59(1):64-72. PubMed ID: 17196703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances on self modified patch for (trans) dermal drug delivery.
    Pandey S; Patil A
    Recent Pat Drug Deliv Formul; 2015; 9(1):88-94. PubMed ID: 24981287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
    Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
    Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic delivery systems: a new approach to evaluate physical properties of transdermal delivery systems (TDS).
    Ehrlich A; Henkel-Ernst J; Schaefer A; Assmussen B; Lücker PW
    Methods Find Exp Clin Pharmacol; 1999; 21(1):69-71. PubMed ID: 10222451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
    Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
    J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI; Boix A; Lauroba J; Colom H; Domenech J
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.